CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY

Objective: to analyze the incidence of giant-cell arteritis (GCA) in the Khabarovsk Territory.Subjects and methods. Ten (11.6%) cases of GCA identified during a 20-year prospective follow-up and treatment of 89 patients with polymyalgia rheumatica (PR) and GCA were analyzed. The rate of some criteri...

Full description

Saved in:
Bibliographic Details
Main Authors: E. N. Otteva, T. Yu. Kocherova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2011-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1291
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399977747415040
author E. N. Otteva
T. Yu. Kocherova
author_facet E. N. Otteva
T. Yu. Kocherova
author_sort E. N. Otteva
collection DOAJ
description Objective: to analyze the incidence of giant-cell arteritis (GCA) in the Khabarovsk Territory.Subjects and methods. Ten (11.6%) cases of GCA identified during a 20-year prospective follow-up and treatment of 89 patients with polymyalgia rheumatica (PR) and GCA were analyzed. The rate of some criteria for the diagnosis of GCA was estimated; its onset and paraclinical data were described. The study enrolled women aged 67.3±2.1 years (range 59 to 76 years). Results and discussion. GCA concurrent with PR was observed in 70% of cases. In addition to temporal arteritis, there was a clinical picture of involvements of the parietal (50%), ocular (30%), occipital (30%), and coronary (10%) arteries. Scalp involvement with necrosis in the parietal area was found in one case. The diagnosis was established after an average of 71±1.6 months. All had elevated ESR, up to 110.2±3.1 on average after Westergren. Seven patients were treated with prednisolone 1.0 mg/kg body weight; due to contraindications, 6 patients had 0.5 mg/kg in combination with pulse therapy with cyclophosphanum 1000 mg intravenously, dropwise once monthly. One female patient died from stroke 4 months later. The late period was marked by the development of osteoporosis with fractures in 2 cases, diabetes mellitus and hypertension in 2, and cancer of the cervix uteri (successfully cured) in one case. Vision loss was seen in one patient whose diagnosis was made 1.5 years later.
format Article
id doaj-art-4e10545623c443c3bea61353d5a2c9d6
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2011-06-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-4e10545623c443c3bea61353d5a2c9d62025-08-20T03:38:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922011-06-01495384510.14412/1995-4484-2011-14591231CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORYE. N. Otteva0T. Yu. Kocherovaelvott@mail.ruObjective: to analyze the incidence of giant-cell arteritis (GCA) in the Khabarovsk Territory.Subjects and methods. Ten (11.6%) cases of GCA identified during a 20-year prospective follow-up and treatment of 89 patients with polymyalgia rheumatica (PR) and GCA were analyzed. The rate of some criteria for the diagnosis of GCA was estimated; its onset and paraclinical data were described. The study enrolled women aged 67.3±2.1 years (range 59 to 76 years). Results and discussion. GCA concurrent with PR was observed in 70% of cases. In addition to temporal arteritis, there was a clinical picture of involvements of the parietal (50%), ocular (30%), occipital (30%), and coronary (10%) arteries. Scalp involvement with necrosis in the parietal area was found in one case. The diagnosis was established after an average of 71±1.6 months. All had elevated ESR, up to 110.2±3.1 on average after Westergren. Seven patients were treated with prednisolone 1.0 mg/kg body weight; due to contraindications, 6 patients had 0.5 mg/kg in combination with pulse therapy with cyclophosphanum 1000 mg intravenously, dropwise once monthly. One female patient died from stroke 4 months later. The late period was marked by the development of osteoporosis with fractures in 2 cases, diabetes mellitus and hypertension in 2, and cancer of the cervix uteri (successfully cured) in one case. Vision loss was seen in one patient whose diagnosis was made 1.5 years later.https://rsp.mediar-press.net/rsp/article/view/1291giant cell arteritispolymyalgia rheumatica,diagnostic criteriaclucocorticoid therapy
spellingShingle E. N. Otteva
T. Yu. Kocherova
CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
Научно-практическая ревматология
giant cell arteritis
polymyalgia rheumatica,
diagnostic criteria
clucocorticoid therapy
title CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
title_full CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
title_fullStr CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
title_full_unstemmed CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
title_short CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
title_sort current view of horton s disease analysis of its cases in the khabarovsk territory
topic giant cell arteritis
polymyalgia rheumatica,
diagnostic criteria
clucocorticoid therapy
url https://rsp.mediar-press.net/rsp/article/view/1291
work_keys_str_mv AT enotteva currentviewofhortonsdiseaseanalysisofitscasesinthekhabarovskterritory
AT tyukocherova currentviewofhortonsdiseaseanalysisofitscasesinthekhabarovskterritory